Transcarent will acquire Accolade for $7.03 per share in cash or $621 million in total. The transaction is expected to close during the 2025 second-quarter after gaining approval from Accolade ...
Transcarent, an employee healthcare navigation company, has entered into a definitive agreement to acquire health benefits platform Accolade for about $621 million, or $7.03 per share in cash. The ...
Transcarent, the One Place for Health and Care, and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in ...
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...
Combined company creates an industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment Transcarent’s Generative AI WayFinding and care ...
We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Accolade Inc (NASDAQ:ACCD) stands against the ...
Transcarent agreed to buy Accolade Inc (NASDAQ:ACCD) Wednesday for $621 million. The purchase price works out to $7.03 per share in cash. Accolade is a Personalized Healthcare company that offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results